NASDAQ · Biotechnology

Alector, Inc. (ALEC) Stock

$2.11 +4.21% NASDAQ: ALEC Healthcare

Valuation

MetricValue
Price$2.11
Market Cap$233.71M
P/E Ratio-1.84
P/B Ratio-22.53
P/S Ratio16.18
EPS (TTM)$-1.39
52-Week High$3.40
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-531.04%
ROA-58.10%
ROCE-75.01%
Gross Margin-695.24%
Operating Margin-695.24%
Net Margin-850.13%
Debt/Equity-3.29
Current Ratio3.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$207.0M$134.0M$97.0M$101.0M$21.0M
Operating Profit$-37.0M$-138.0M$-152.0M$-145.0M$-146.0M
Net Profit$-36.0M$-133.0M$-130.0M$-119.0M$-143.0M
EPS$-0.45$-1.62$-1.56$-1.23$-1.39
Op Margin-18.0%-103.2%-156.3%-144.2%-692.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$815.0M$788.0M$622.0M$468.0M$293.0M
Total Liabilities$514.0M$573.0M$488.0M$342.0M$263.0M
Cash$329.0M$154.0M$75.0M$33.0M$66.0M
Borrowings$48.0M$43.0M$39.0M$43.0M$36.0M

Latest News

GSK ends brain drug alliance with Alector BioPharma Dive · Jul 9, 2026 Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough Simply Wall St. · Jun 19, 2026 How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus Simply Wall St. · May 19, 2026 Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates Zacks · May 7, 2026 Alector: Q1 Earnings Snapshot Associated Press · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$299.0M$-20.0M$-184.0M$-230.0M$-184.0M
Investing Cash Flow$-53.0M$-163.0M$100.0M$106.0M$197.0M
Financing Cash Flow$30.0M$0$0$1.0M$0
Net Cash Flow$279.0M$-175.0M$-80.0M$-41.0M$33.0M
Free Cash Flow$295.0M$-24.0M$-187.0M$-231.0M$-184.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.26
EV / EBITDA-1.78
FCF Yield-70.63%
Quick Ratio5.26
Interest Coverage0.00
Return 1Y-16.77%
Return 3Y-78.55%
Return 5Y-95.84%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.71 -1.09% 38.93 $4.95T 0.32%
MSFTMicrosoft Corporation $535.72 +2.51% 28.68 $3.98T 0.76%
GOOGLAlphabet Inc. $352.57 +1.23% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $262.61 +3.37% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $719.65 -0.17% 27.93 $1.83T 0.28%

About Alector, Inc.

Alector, Inc. is led by CEO Arnon Rosenthal, publicly traded since 2019.

Alector, Inc. (ALEC) stock trades at $2.11 with a market capitalization of $233.71M. The stock is valued at a price-to-earnings (P/E) ratio of -1.84, price-to-book of -22.53, price-to-sales of 16.18. Over the past 52 weeks the stock has ranged between $1.09 and $3.40, and currently trades 37.9% below its 52-week high.

On profitability, Alector, Inc. generates a return on equity (ROE) of -531.04%, return on capital employed of -75.01%, an operating margin of -695.24%, a net profit margin of -850.13%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.87 +0.54% JNJ Johnson & Johnson $260.78 +1.68% ABBV AbbVie Inc. $276.48 +1.49% MRK Merck & Company, Inc. Common Stock (new) $146.30 +2.75% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.88 +2.41% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $657.57 +0.86% AMGN Amgen Inc. $415.91 +2.08% GILD Gilead Sciences, Inc. $150.59 +2.37% ABT Abbott Laboratories $99.58 +1.10% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides